Is Concentrix Corp. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears undervalued relative to its peers, with a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. shows a P/E of 10.02 and an EV to EBITDA of 5.12, highlighting Concentrix's more favorable valuation metrics.
Despite its attractive valuation, Concentrix has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.87% compared to the S&P 500's 16.30%. This underperformance may suggest that the market has not yet recognized the company's potential, reinforcing the notion that Concentrix is undervalued.